Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07401797 · ClinicalTrials.gov registry record
Specimens for Lung Cancer Panel Design
A clinical trial of Lung Nodules, sponsored by Maverix Medical.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT07401797: Recruiting study of Lung Nodules, sponsored by Maverix Medical.
NCT07401797 is a study of Lung Nodules that is actively recruiting participants, run by Maverix Medical. The registered enrollment target is 2,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07401797, a study of Lung Nodules, is actively recruiting participants, sponsored by Maverix Medical.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational study designed to determine the optimal combination of biomarkers and clinical data for the early detection, confirmation, and better treatment of lung cancer including minimizing recurrence.
Primary Outcome
Analytical validity, clinical validity, and clinical utility. Ability to correctly re-risk indeterminate nodules and ability to change clinical care based on hypothetical treatment plans for different test outcomes. Actual test results will not be provided to physicians, and actual care will not be affected.
Conditions Studied
Study Locations (1)
Arizona
- Maverix Medical - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2024-08-07 |
| Est. Completion | 2029-12-31 |
What NCT07401797 shows while recruiting
NCT07401797 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Lung Nodules appearing as the primary indexed condition, and to 0 interventions.
NCT07401797 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT07401797 about?
NCT07401797 is a clinical study titled "Specimens for Lung Cancer Panel Design". This is an observational study designed to determine the optimal combination of biomarkers and clinical data for the early detection, confirmation, and better treatment of lung cancer including minimizing recurrence.
What is the current status of trial NCT07401797?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2024-08-07. Estimated completion is 2029-12-31.
What conditions does trial NCT07401797 study?
This clinical trial studies the following conditions: Lung Nodules.
Who is sponsoring clinical trial NCT07401797?
This trial is sponsored by Maverix Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07401797 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Nodules
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI